Drug Shortage Report for CEFAZOLIN FOR INJECTION
Report ID | 88563 |
Drug Identification Number | 02437112 |
Brand name | CEFAZOLIN FOR INJECTION |
Common or Proper name | CEFAZOLIN FOR INJECTION |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CEFAZOLIN |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 25 VIALS |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-07-08 |
Estimated end date | |
Actual end date | 2019-12-18 |
Shortage status | Resolved |
Updated date | 2019-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-12-19 | English | Compare |
v9 | 2019-12-18 | French | Compare |
v8 | 2019-12-18 | English | Compare |
v7 | 2019-12-18 | French | Compare |
v6 | 2019-12-18 | English | Compare |
v5 | 2019-08-16 | French | Compare |
v4 | 2019-08-16 | English | Compare |
v3 | 2019-07-09 | English | Compare |
v2 | 2019-07-05 | French | Compare |
v1 | 2019-07-05 | English | Compare |
Showing 1 to 10 of 10